Higher anticoagulation targets and risk of thrombotic events in severe COVID-19 patients: bi-center cohort study.

Julie HelmsFrançois SeveracHamid MerdjiMaleka SchenckRaphaël Clere-JehlMathieu BaldaciniMickaël OhanaLélia GrunebaumVincent CastelainEduardo Anglés-CanoLaurent SattlerFerhat Mezianinull null

Published in: Annals of intensive care (2021)

Increasing the anticoagulation of severe COVID-19 patients to a therapeutic level might decrease thrombotic complications without increasing their bleeding risk.

Keyphrases

atrial fibrillation
sars cov
venous thromboembolism
early onset
drug induced